Search results for: hospital

Where Will Kinase Inhibitors Fit into the RA Treatment Mix?

Vanessa Caceres | March 8, 2012

Presenters at “Looking Ahead to Kinase Inhibition in Rheumatoid Arthritis,” a session here at the 2011 ACR/ARHP Annual Scientific Meeting, delved into some of the big questions that rheumatology faces with kinase inhibitor use.

Susac’s Syndrome: Confusion, Expressive Aphasia, Gait Instability

Candace H. Feldman, MD, MPH, Gwendolyn Kane-Wagner, MD | March 8, 2012

A 49-year-old man presented to the hospital with confusion, dysarthria, expressive aphasia, and progressive gait instability.

Information on New Drug Approvals and Medication Safety

Michele B. Kaufman, PharmD, BCGP | March 8, 2012

Rheumatology-related drug safety, approvals, and what’s in the pipeline.

How to Retire from Your Medical Practice

Steven M. Harris, Esq. | March 8, 2012

If you are a physician nearing retirement, it is important that you plan, discuss, and make contractual agreements that will allow you to accomplish your goals and changing needs.

Scientists Pinpoint Three HLA Proteins Linked to Seropositive Rheumatoid Arthritis

Carrie Printz | February 28, 2012

Researchers have identified five amino acids in three HLA proteins that explain most of the association between major histocompatibility complex (MHC) and seropositive rheumatoid arthritis (RA).

Unexpected Benefits of Bisphosphonates after Hip Fracture

Cathleen Colon-Emeric, MD, MHS | February 3, 2012

Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.

Challenges and Rewards of a Physician Executive Career

Catherine Kolonko | February 3, 2012

The job of a physician executive offers a different set of challenges for rheumatologists familiar with research and patient care.

Dermatology Case Answer

Joseph F. Merola, MD | February 3, 2012

A 64-year-old man with history of type-II diabetes (well controlled on sitagliptin/metformin), hypertension, and dyslipidemia presents with complaints of an increasingly painful left lower-extremity lesion present for two to three months.

A Comparison of the Canadian and U.S. Healthcare Systems

Simon M. Helfgott, MD | February 3, 2012

The joys and the hazards of the Canadian single-payer universal healthcare program Canadian and the high-capacity and costly U.S. healthcare system.

Trailblazers in Rheumatology

Staff | February 3, 2012

Since the beginning of their medical careers, Rodanthi C. Kitridou, MD, and Bevra H. Hahn, MD, have seen a huge shift in the demographics of the field.